G9a coordinates with the RPA complex to promote DNA damage repair and cell survival

Histone methyltransferase G9a has critical roles in promoting cancer-cell growth and gene suppression, but whether it is also associated with the DNA damage response is rarely studied. Here, we report that loss of G9a impairs DNA damage repair and enhances the sensitivity of cancer cells to radiation and chemotherapeutics. In response to DNA double-strand breaks (DSBs), G9a is phosphorylated at serine 211 by casein kinase 2 (CK2) and recruited to chromatin. The chromatin-enriched G9a can then directly interact with replication protein A (RPA) and promote loading of the RPA and Rad51 recombinase to DSBs. This mechanism facilitates homologous recombination (HR) and cell survival. We confirmed the interaction between RPA and G9a to be critical for RPA foci formation and HR upon DNA damage. Collectively, our findings demonstrate a regulatory pathway based on CK2–G9a–RPA that permits HR in cancer cells and provide further rationale for the use of G9a inhibitors as a cancer therapeutic.

Download Full-text

GLP-catalyzed H4K16me1 promotes 53BP1 recruitment to permit DNA damage repair and cell survival

Nucleic Acids Research ◽

10.1093/nar/gkz897 ◽

2019 ◽

Vol 47 (21) ◽

pp. 10977-10993 ◽

Cited By ~ 4

Author(s):

Xiaopeng Lu ◽

Ming Tang ◽

Qian Zhu ◽

Qiaoyan Yang ◽

Zhiming Li ◽

...

Keyword(s):

Dna Damage ◽

Cell Survival ◽

Dna Damage Repair ◽

Binding Activity ◽

Critical Event ◽

Dna Double Strand Breaks ◽

End Joining ◽

Strand Breaks ◽

Damage Repair ◽

Underlying Mechanisms

Abstract The binding of p53-binding protein 1 (53BP1) to damaged chromatin is a critical event in non-homologous DNA end joining (NHEJ)-mediated DNA damage repair. Although several molecular pathways explaining how 53BP1 binds damaged chromatin have been described, the precise underlying mechanisms are still unclear. Here we report that a newly identified H4K16 monomethylation (H4K16me1) mark is involved in 53BP1 binding activity in the DNA damage response (DDR). During the DDR, H4K16me1 rapidly increases as a result of catalyzation by the histone methyltransferase G9a-like protein (GLP). H4K16me1 shows an increased interaction level with 53BP1, which is important for the timely recruitment of 53BP1 to DNA double-strand breaks. Differing from H4K16 acetylation, H4K16me1 enhances the 53BP1–H4K20me2 interaction at damaged chromatin. Consistently, GLP knockdown markedly attenuates 53BP1 foci formation, leading to impaired NHEJ-mediated repair and decreased cell survival. Together, these data support a novel axis of the DNA damage repair pathway based on H4K16me1 catalysis by GLP, which promotes 53BP1 recruitment to permit NHEJ-mediated DNA damage repair.

Download Full-text

RepID-deficient cancer cells are sensitized to a drug targeting p97/VCP segregase

Molecular & Cellular Toxicology ◽

10.1007/s13273-021-00121-0 ◽

2021 ◽

Author(s):

Sang-Min Jang ◽

Christophe E. Redon ◽

Haiqing Fu ◽

Fred E. Indig ◽

Mirit I. Aladjem

Keyword(s):

Dna Damage ◽

Cancer Cells ◽

Cell Sorting ◽

Clonogenic Survival ◽

Double Strand Breaks ◽

Dna Double Strand Breaks ◽

Strand Breaks ◽

Ubiquitinated Proteins ◽

Damage Response ◽

Survival Assay

Abstract Background The p97/valosin-containing protein (VCP) complex is a crucial factor for the segregation of ubiquitinated proteins in the DNA damage response and repair pathway. Objective We investigated whether blocking the p97/VCP function can inhibit the proliferation of RepID-deficient cancer cells using immunofluorescence, clonogenic survival assay, fluorescence-activated cell sorting, and immunoblotting. Result p97/VCP was recruited to chromatin and colocalized with DNA double-strand breaks in RepID-deficient cancer cells that undergo spontaneous DNA damage. Inhibition of p97/VCP induced death of RepID-depleted cancer cells. This study highlights the potential of targeting p97/VCP complex as an anticancer therapeutic approach. Conclusion Our results show that RepID is required to prevent excessive DNA damage at the endogenous levels. Localization of p97/VCP to DSB sites was induced based on spontaneous DNA damage in RepID-depleted cancer cells. Anticancer drugs targeting p97/VCP may be highly potent in RepID-deficient cells. Therefore, we suggest that p97/VCP inhibitors synergize with RepID depletion to kill cancer cells.

Download Full-text

Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.1906102116 ◽

2019 ◽

Vol 116 (39) ◽

pp. 19552-19562 ◽

Cited By ~ 7

Author(s):

Justine Sitz ◽

Sophie Anne Blanchet ◽

Steven F. Gameiro ◽

Elise Biquand ◽

Tia M. Morgan ◽

...

Keyword(s):

Cervical Cancer ◽

Dna Damage ◽

Cancer Cells ◽

Genomic Instability ◽

E3 Ligase ◽

Human Papillomaviruses ◽

Double Strand Breaks ◽

Nuclear Bodies ◽

Dna Double Strand Breaks ◽

Strand Breaks

High-risk human papillomaviruses (HR-HPVs) promote cervical cancer as well as a subset of anogenital and head and neck cancers. Due to their limited coding capacity, HPVs hijack the host cell’s DNA replication and repair machineries to replicate their own genomes. How this host–pathogen interaction contributes to genomic instability is unknown. Here, we report that HPV-infected cancer cells express high levels of RNF168, an E3 ubiquitin ligase that is critical for proper DNA repair following DNA double-strand breaks, and accumulate high numbers of 53BP1 nuclear bodies, a marker of genomic instability induced by replication stress. We describe a mechanism by which HPV E7 subverts the function of RNF168 at DNA double-strand breaks, providing a rationale for increased homology-directed recombination in E6/E7-expressing cervical cancer cells. By targeting a new regulatory domain of RNF168, E7 binds directly to the E3 ligase without affecting its enzymatic activity. As RNF168 knockdown impairs viral genome amplification in differentiated keratinocytes, we propose that E7 hijacks the E3 ligase to promote the viral replicative cycle. This study reveals a mechanism by which tumor viruses reshape the cellular response to DNA damage by manipulating RNF168-dependent ubiquitin signaling. Importantly, our findings reveal a pathway by which HPV may promote the genomic instability that drives oncogenesis.

Download Full-text

Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage

Strahlentherapie und Onkologie ◽

10.1007/s00066-021-01774-5 ◽

2021 ◽

Author(s):

Xinrui Zhang ◽

Mariana Bobeica ◽

Michael Unger ◽

Anastasia Bednarz ◽

Bjoern Gerold ◽

...

Keyword(s):

Prostate Cancer ◽

Dna Damage ◽

Cancer Cells ◽

Metabolic Activity ◽

Focused Ultrasound ◽

Double Strand Breaks ◽

High Intensity Focused Ultrasound ◽

Dna Double Strand Breaks ◽

Strand Breaks

Abstract Purpose High-intensity focused ultrasound (HIFU/FUS) has expanded as a noninvasive quantifiable option for hyperthermia (HT). HT in a temperature range of 40–47 °C (thermal dose CEM43 ≥ 25) could work as a sensitizer to radiation therapy (RT). Here, we attempted to understand the tumor radiosensitization effect at the cellular level after a combination treatment of FUS+RT. Methods An in vitro FUS system was developed to induce HT at frequencies of 1.147 and 1.467 MHz. Human head and neck cancer (FaDU), glioblastoma (T98G), and prostate cancer (PC-3) cells were exposed to FUS in ultrasound-penetrable 96-well plates followed by single-dose X‑ray irradiation (10 Gy). Radiosensitizing effects of FUS were investigated by cell metabolic activity (WST‑1 assay), apoptosis (annexin V assay, sub-G1 assay), cell cycle phases (propidium iodide staining), and DNA double-strand breaks (γH2A.X assay). Results The FUS intensities of 213 (1.147 MHz) and 225 W/cm2 (1.467 MHz) induced HT for 30 min at mean temperatures of 45.20 ± 2.29 °C (CEM43 = 436 ± 88) and 45.59 ± 1.65 °C (CEM43 = 447 ± 79), respectively. FUS improves the effect of RT significantly by reducing metabolic activity in T98G cells 48 h (RT: 96.47 ± 8.29%; FUS+RT: 79.38 ± 14.93%; p = 0.012) and in PC-3 cells 72 h (54.20 ± 10.85%; 41.01 ± 11.17%; p = 0.016) after therapy, but not in FaDu cells. Mechanistically, FUS+RT leads to increased apoptosis and enhancement of DNA double-strand breaks compared to RT alone in T98G and PC-3 cells. Conclusion Our in vitro findings demonstrate that FUS has good potential to sensitize glioblastoma and prostate cancer cells to RT by mainly enhancing DNA damage.

Download Full-text

DNA structure-specific priming of ATR activation by DNA-PKcs

The Journal of Cell Biology ◽

10.1083/jcb.201304139 ◽

2013 ◽

Vol 202 (3) ◽

pp. 421-429 ◽

Cited By ~ 29

Author(s):

Sophie Vidal-Eychenié ◽

Chantal Décaillet ◽

Jihane Basbous ◽

Angelos Constantinou

Keyword(s):

Dna Damage ◽

Ataxia Telangiectasia ◽

Protein A ◽

Dna Structure ◽

Specific Response ◽

Dna Double Strand Breaks ◽

Strand Breaks ◽

Synergistic Activation ◽

Dependent Protein ◽

Specific Priming

Three phosphatidylinositol-3-kinase–related protein kinases implement cellular responses to DNA damage. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia-telangiectasia mutated respond primarily to DNA double-strand breaks (DSBs). Ataxia-telangiectasia and RAD3-related (ATR) signals the accumulation of replication protein A (RPA)–covered single-stranded DNA (ssDNA), which is caused by replication obstacles. Stalled replication intermediates can further degenerate and yield replication-associated DSBs. In this paper, we show that the juxtaposition of a double-stranded DNA end and a short ssDNA gap triggered robust activation of endogenous ATR and Chk1 in human cell-free extracts. This DNA damage signal depended on DNA-PKcs and ATR, which congregated onto gapped linear duplex DNA. DNA-PKcs primed ATR/Chk1 activation through DNA structure-specific phosphorylation of RPA32 and TopBP1. The synergistic activation of DNA-PKcs and ATR suggests that the two kinases combine to mount a prompt and specific response to replication-born DSBs.

Download Full-text